THE Cannabidiol (CBD) MOMENTUM

CNN has been running a series by the noted neurosurgeon Dr. Sanjay Gupta discussing why his thinking about the medical benefits of cannabis has undergone a 180° change.

Gupta: Why I changed my mind on Cannabis

Gupta has stated: I am more convinced than ever that it is irresponsible to not provide the best care that we can, care that may often involve cannabinoids. “ I am not backing down . . . I am doubling down. “

And Dr. Gupta further states, “The science is there. This isn’t anecdotal.” “We have been terribly and systematically misled for nearly 70 years in the United States, and I apologize for my own role in that.”

“I am here to apologize. I apologize because I didn’t look hard enough, until now. I didn’t look far enough. I didn’t review papers from smaller labs in other countries doing some remarkable research, and I was too dismissive of the loud chorus of legitimate patients whose symptoms improved on cannabis.” (emphasis added)

From someone who publicly parroted the ‘party line’ that there were no known medical benefits to marijuana, Dr. Gupta has finally learned how wrong he was. He now sees the potential that THC and Cannabinoids have to treat many conditions that are either untreatable or poorly treated by current pharmaceuticals. And he understands how releasing the shackles on legitimate research can open the door for many new discoveries.

We believe Dr. Gupta is understating the case.

When CNN and NBC Dateline’s Harry Smith both highlight the real benefits of Cannabinoids, and CBD Oil in particular, to real patients, and especially young epileptic children who would possibly die without it, then it becomes easy to see how quickly the laws could possibly change.

Harry Smith, June 7, 2015, Dateline–dateline–growing-hope-464847427875

Even though both Gupta and Smith focus mostly on just a single disease, epilepsy, that potential alone can be a life-changing benefit for many thousands. As Gupta notes, “…the American Epilepsy Society (AES) says that there are a million people for whom existing therapies do not control their seizures.

The society recently said anecdotes about medical cannabis “give reason for hope” and said it supports “well-controlled studies that will lead to a better understanding of the disease and the development of safe and effective treatments.” To quote the American Epilepsy Society directly; “AES believes that there must be more research done on CBD-rich marijuana**. “ (** from an AES Letter to the DEA, April 24, 2014)